Literature DB >> 6218993

Uptake and localization of 99mTc-methylene diphosphonate in mouse osteosarcoma.

H Nakashima, H Ochi, N Yasui, H Hamada, K Ono.   

Abstract

The localization of 99mTc-methylene diphosphonate (99mTc-MDP) in mouse osteosarcoma was studied using a skeletal scintigraphic method and macro- and microautoradiographic methods. On the skeletal scintigraph, the tumor showed a high uptake of 99mTc-MDP and its concentration was about 20 times as high as the value seen in the muscular tissue. The macroautoradiography showed high activity in the tumor bone region and little activity in the nonossified region. On the microautoradiography, the activity of 99mTc-MDP was localized in the mineralized matrix of tumor bone and was almost nil in the nonmineralized matrix (osteoid) and the tumor cells. These findings indicate that the mineralization of the tumor bone matrix plays an important role in 99mTc-MDP uptake in osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218993     DOI: 10.1007/bf00571644

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  22 in total

1.  AUTORADIOGRAPHIC LOCALIZATION OF STRONTIUM 85 IN OSTEOSARCOMAS.

Authors:  L E APPELGREN; A NILSSON; S ULLBERG
Journal:  Acta Radiol Ther Phys Biol       Date:  1963-12

Review 2.  Bone scanning: radionuclidic reaction mechanisms.

Authors:  A G Jones; M D Francis; M A Davis
Journal:  Semin Nucl Med       Date:  1976-01       Impact factor: 4.446

3.  Uptake and retention of strontium 90 in strontium-90-induced osteosarcomas. II.

Authors:  A NILSSON; S ULLBERG
Journal:  Acta radiol       Date:  1962-06       Impact factor: 1.990

4.  Fluorine-18 bone scintigraphy in children with osteosarcoma or Ewing's sarcoma.

Authors:  B J McNeil; J R Cassady; C F Geiser; N Jaffe; D Traggis; S Treves
Journal:  Radiology       Date:  1973-12       Impact factor: 11.105

5.  Fluorine-18 uptake and localization in soft tissue deposits of osteogenic sarcoma in rat and man.

Authors:  D H Woodbury; W H Beierwaltes
Journal:  J Nucl Med       Date:  1967-09       Impact factor: 10.057

6.  Radionuclide skeletal survey for pediatric neoplasms.

Authors:  D L Gilday; J M Ash; B J Reilly
Journal:  Radiology       Date:  1977-05       Impact factor: 11.105

7.  A study of irradiated bone. III. Scintigraphic and radiographic detection of radiation-induced osteosarcomas.

Authors:  M A King; G W Casarett; D A Weber; F A Burgener; R E O'Mara; G A Wilson
Journal:  J Nucl Med       Date:  1980-05       Impact factor: 10.057

8.  Characteristics of osteosarcoma cells in culture.

Authors:  K Amitani; Y Nakata
Journal:  Clin Orthop Relat Res       Date:  1977 Jan-Feb       Impact factor: 4.176

9.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

10.  Localization of Tc-99m MDP in epiphyseal growth plates of rats.

Authors:  S B Christensen; O W Krogsgaard
Journal:  J Nucl Med       Date:  1981-03       Impact factor: 10.057

View more
  4 in total

1.  Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology.

Authors:  J Knop; G Delling; U Heise; K Winkler
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

Review 2.  Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  A Fitton; D McTavish
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

3.  Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma.

Authors:  V Edeline; F Frouin; J P Bazin; M Di Paola; C Kalifa; G Contesso; C Parmentier; J Lumbroso; R Di Paola
Journal:  Eur J Nucl Med       Date:  1993-12

4.  Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma.

Authors:  F Wingen; H Sterz; H Blum; H Möller; W Pittermann; B L Pool; H J Sinn; H Spring; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.